IA
LLY icon

Intellus Advisors’s Eli Lilly LLY Stock Holding History

Intellus Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Buy
13,255
+110
+0.8% +$112K 1.67% 21
2025
Q4 		$14.1M Buy
13,145
+5,679
+76% +$5.43M 1.87% 22
2025
Q3 		$5.7M Sell
7,466
-532
-7% -$396K 0.78% 24
2025
Q2 		$6.23M Buy
+7,998
New +$6.22M 0.93% 24

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Intellus Advisors's LLY Position: Q1 2026 in Review

Intellus Advisors increased its Eli Lilly (LLY) stake by 0.84% in Q1 2026, buying an estimated $112K and bringing the position to 13,255 shares worth $12.2M. The position accounts for 1.67% of the portfolio, ranked #21.

Intellus Advisors first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $14.1M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Intellus Advisors held 13,255 shares of Eli Lilly worth $12.2M as of Q1 2026.
  • Intellus Advisors bought 110 Eli Lilly shares in Q1 2026, an estimated $112K.
  • Eli Lilly made up 1.67% of Intellus Advisors's portfolio in Q1 2026, its #21 holding.
  • Intellus Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Intellus Advisors's Eli Lilly position peaked at $14.1M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Intellus Advisors's 13F filing for Q1 2026, filed 7 May 2026.